Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders
- PMID: 37465321
- PMCID: PMC10350538
- DOI: 10.3389/fnagi.2023.1193483
Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects both motor and non-motor functions, including sleep regulation. Emerging evidence suggests that the hypothalamus, a brain region that plays a critical role in sleep-wake regulation, may be involved in the pathogenesis of ALS-related sleep disturbances. In this review, we have summarized results of studies on sleep disorders in ALS published between 2000 and 2023. Thereafter, we examined possible mechanisms by which hypothalamic dysfunctions may contribute to ALS-related sleep disturbances. Achieving a deeper understanding of the relationship between hypothalamic dysfunction and sleep disturbances in ALS can help improve the overall management of ALS and reduce the burden on patients and their families.
Keywords: amyotrophic lateral sclerosis; circadian rhythm; hypothalamus; neurodegeneration; sleep disorders.
Copyright © 2023 Gnoni, Zoccolella, Giugno, Urso, Tamburrino, Filardi and Logroscino.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.Acta Neuropathol Commun. 2019 Dec 2;7(1):189. doi: 10.1186/s40478-019-0845-9. Acta Neuropathol Commun. 2019. PMID: 31791419 Free PMC article.
-
Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review.Amyotroph Lateral Scler Frontotemporal Degener. 2021 May;22(3-4):161-169. doi: 10.1080/21678421.2020.1844755. Epub 2020 Nov 16. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 33191797
-
Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis.Neuropathol Appl Neurobiol. 2021 Dec;47(7):979-989. doi: 10.1111/nan.12709. Epub 2021 Apr 9. Neuropathol Appl Neurobiol. 2021. PMID: 33755993
-
Increased orexin expression promotes sleep/wake disturbances in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.Chin Med J (Engl). 2015 Jan 20;128(2):239-44. doi: 10.4103/0366-6999.149214. Chin Med J (Engl). 2015. PMID: 25591569 Free PMC article.
-
Hypothalamus and weight loss in amyotrophic lateral sclerosis.Handb Clin Neurol. 2021;180:327-338. doi: 10.1016/B978-0-12-820107-7.00020-3. Handb Clin Neurol. 2021. PMID: 34225938 Review.
Cited by
-
Prediction of antioxidant capacity, age, and sex on sleep impairment in patients with amyotrophic lateral sclerosis.Sci Rep. 2025 Jul 1;15(1):21145. doi: 10.1038/s41598-025-07729-5. Sci Rep. 2025. PMID: 40595276 Free PMC article. Clinical Trial.
-
Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review.Neurochem Res. 2024 Mar;49(3):568-582. doi: 10.1007/s11064-023-04086-5. Epub 2023 Dec 18. Neurochem Res. 2024. PMID: 38108952 Review.
-
Volume loss in the left anterior-superior subunit of the hypothalamus in amyotrophic lateral sclerosis.CNS Neurosci Ther. 2024 Jun;30(6):e14801. doi: 10.1111/cns.14801. CNS Neurosci Ther. 2024. PMID: 38887187 Free PMC article.
-
Association between sleep and ALS-FTSD: A Prospective Cohort Study based on 396,918 UK biobank participants.Transl Psychiatry. 2025 Apr 4;15(1):123. doi: 10.1038/s41398-025-03328-0. Transl Psychiatry. 2025. PMID: 40185700 Free PMC article.
-
Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions.J Neurol. 2024 Jul;271(7):3953-3977. doi: 10.1007/s00415-024-12455-5. Epub 2024 May 28. J Neurol. 2024. PMID: 38805053 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous